Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × TroVax × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 8 Thoracic 1 Other solid neoplasm 1 Gynecologic 1 Gastrointestinal 1

Conditions

Recurrence 1 Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 572 Carboplatin 520 Cisplatin 347 Bevacizumab 250 pembrolizumab 223 Gemcitabine 153 liposomal doxorubicin 125 Topotecan 125 Cyclophosphamide 125 olaparib 121 Taxes 114 Radiotherapy 110 Docetaxel 94 Brachytherapy 89 Doxorubicin 84 Drug Therapy 80 niraparib 75 Nivolumab 70 Magnetic Resonance Spectroscopy 69 Specimen Handling 64 fludarabine 55 Biopsy 55 Hyperthermic Intraperitoneal Chemotherapy 53 Filgrastim 52 Letrozole 50 Oxaliplatin 48 durvalumab 47 Immunoglobulin G 47 atezolizumab 46 Platinum 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01556841 2019-05-09

TRIOC

University College, London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡